Mark Gudesblatt
Mark Gudesblatt publishes mostly in Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health, on topics such as Multiple Sclerosis Research Studies, Dementia and Cognitive Impairment Research and Amyotrophic Lateral Sclerosis Research.
- World rank
- #1,276,861 of 7,710,434 ranked researchers
- Rank in United States
- #406,856 of 1,627,098
- Works
- 147
- Citations
- 3.3k
- Citations per work
- 22.3
What does Mark Gudesblatt research?
Mark Gudesblatt's work is mostly in Medicine (47%), Health Professions (5%), Neuroscience (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7752.5%
- Medicine7047.3%
- Health Professions85.2%
- Everything else5939.8%
- Life Sciences117.7%
- 1Pathology and Forensic Medicine21% of their works
- 2Neurology16% of their works
- 3Psychiatry and Mental health10% of their works
- 4Physical Therapy, Sports Therapy and Rehabilitation5% of their works
- 5Neurology4% of their works
- 6Molecular Biology3% of their works
Research topics
- Multiple Sclerosis Research Studies
- Dementia and Cognitive Impairment Research
- Amyotrophic Lateral Sclerosis Research
- Balance, Gait, and Falls Prevention
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Peripheral Neuropathies and Disorders
Which keywords describe Mark Gudesblatt's research?
The keywords of their largest research topics: Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Parkinson's Disease, Neurodegeneration, Neurological Disorders, Alzheimer's Disease and Mild Cognitive Impairment.
- Neurotoxins
- Deep Brain Stimulation
- Botulinum Toxin
- Gait Speed
- Dopaminergic Neurons
- TDP-43
- Mild Cognitive Impairment
- Neurological Disorders
- Parkinson's Disease
- Multiple Sclerosis
- Diagnostic Criteria
- Neuromyelitis Optica
- Neurodegeneration
- Alzheimer's Disease
- FUS/TLS
- Treatment
- Fall Risk
- a-Synuclein
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Guillain-Barré Syndrome
- Subthalamic Nucleus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Diagnostic Criteria742 topics
- Multiple Sclerosis631 topic
- Neuromyelitis Optica631 topic
- Parkinson's Disease293 topics
- Neurodegeneration252 topics
- Neurological Disorders213 topics
- Alzheimer's Disease191 topic
- Mild Cognitive Impairment191 topic
- FUS/TLS141 topic
- TDP-43141 topic
- Treatment142 topics
- Dopaminergic Neurons111 topic
- Fall Risk111 topic
- Gait Speed111 topic
- a-Synuclein111 topic
- Botulinum Toxin71 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy71 topic
- Deep Brain Stimulation71 topic
- Guillain-Barré Syndrome71 topic
- Neurotoxins71 topic
- Subthalamic Nucleus71 topic
Where does Mark Gudesblatt work?
Mark Gudesblatt's main affiliation in the publication record is Urology Associates, United States.
How many publications and citations does Mark Gudesblatt have?
OpenAlex counts 147 works and 3,284 citations for Mark Gudesblatt, an h-index of 29, ranking #1,276,861 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Gudesblatt. Posts are plain text and can be reported.